Loading...
OTCM
VBACY
Market cap2.92bUSD
, Last price  
USD
Name

Virbac SA

Chart & Performance

D1W1MN
P/E
—
P/S
—
EPS
17.35
Div Yield, %
—
Shrs. gr., 5y
-0.13%
Rev. gr., 5y
8.29%
Revenues
1.40b
+12.07%
372,403,000401,636,000438,548,000443,355,000467,418,000572,830,000623,059,000695,155,000736,080,000773,116,000852,623,000871,828,000861,882,000868,932,000938,342,000934,198,0001,063,964,9991,216,187,0001,246,901,0001,397,380,000
Net income
145m
+19.78%
19,799,00024,913,00031,873,00036,287,00039,676,00064,313,00058,555,00066,625,00060,523,00063,596,0009,405,00034,646,000-2,575,00020,099,00051,550,000136,039,000113,162,000121,967,000121,298,000145,290,000
CFO
204m
+71.68%
35,764,00048,807,00050,451,00042,280,00064,778,00083,897,00061,781,00097,033,00073,633,00076,447,00046,221,000142,449,000107,806,00083,623,000131,609,000110,221,000126,292,00098,984,000118,957,000204,221,000
Earnings
Sep 11, 2025

Profile

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
URL
https://corporate.virbac.com/
IPO date
Jan 01, 1985
Employees
5,386
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,397,380
12.07%
1,246,901
2.53%
1,216,187
14.31%
Cost of revenue
456,117
824,232
788,916
Unusual Expense (Income)
NOPBT
941,263
422,669
427,271
NOPBT Margin
67.36%
33.90%
35.13%
Operating Taxes
62,478
53,520
45,249
Tax Rate
6.64%
12.66%
10.59%
NOPAT
878,785
369,149
382,022
Net income
145,290
19.78%
121,298
-0.55%
121,967
7.78%
Dividends
(11,054)
(11,165)
(10,573)
Dividend yield
0.42%
0.37%
0.55%
Proceeds from repurchase of equity
(19,422)
(14,275)
BB yield
0.64%
0.74%
Debt
Debt current
11,550
54,491
46,084
Long-term debt
64,654
100,763
45,406
Deferred revenue
1,450
1,846
Other long-term liabilities
314,007
48,137
58,123
Net debt
(95,243)
(31,138)
(96,572)
Cash flow
Cash from operating activities
204,221
118,957
98,984
CAPEX
(69,246)
(41,042)
(53,576)
Cash from investing activities
(428,689)
(121,869)
(54,832)
Cash from financing activities
138,585
(2,564)
(34,755)
FCF
765,475
287,775
295,148
Balance
Cash
153,943
175,906
177,383
Long term investments
17,504
10,486
10,679
Excess cash
101,578
124,047
127,253
Stockholders' equity
1,043,403
903,383
955,504
Invested Capital
1,293,934
955,567
825,576
ROIC
78.13%
41.45%
49.94%
ROCE
67.45%
38.04%
42.50%
EV
Common stock shares outstanding
8,379
8,437
8,454
Price
316.50
-11.96%
359.50
57.68%
228.00
-46.29%
Market cap
2,651,919
-12.57%
3,033,178
57.37%
1,927,424
-46.25%
EV
2,556,962
3,011,656
1,830,501
EBITDA
998,615
470,188
473,087
EV/EBITDA
2.56
6.41
3.87
Interest
8,882
3,691
Interest/NOPBT
2.10%
0.86%